How Inclusion In Precision Medicine Could Drive Market Success And Minimize Disparities

Authors

Stephane Budel

Founding Partner

Related Insights

Clinical Diagnostics

Liquid Biopsy | October Roundup

October brought numerous updates in the regulatory world for Liquid Biopsy (LBx), with additional developments in partnerships, clinical findings, and fundraising.

November 8, 2022

Clinical Diagnostics

Pathology Visions 2022 - DeciBio Highlights: Growing Traction for Digital Pathology

Our experts highlight some of the key Digital Pathology trends and themes from the 2022 Pathology Visions conference.

October 28, 2022

Clinical Diagnostics

New and Established Early Detection Companies Work to Solidify their Standings: This is a Race to Watch

Building off last year's blog, this year we recap updates in the early detection (EDx) landscape that focus on last year’s developments, identify emerging players and technologies, and highlight some geographical considerations.

October 24, 2022

Clinical Diagnostics

Worldwide Liquid Biopsy (LBx) Market Forecasted to Grow at 46% p.a., Reaching $8.6B by 2027 – Market Report by DeciBio Consulting LLC

DeciBio released a second edition liquid biopsy report that takes an updated and comprehensive look at the liquid biopsy (LBx) landscape.

October 19, 2022

View All Insights

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.